Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Involvement of CD74 in head and neck squamous cell carcinomas.

Kindt N, Lechien JR, Nonclercq D, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2014 Jun;140(6):937-47. doi: 10.1007/s00432-014-1648-9. Epub 2014 Mar 25.

PMID:
24663824
2.

Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.

Kindt N, Laurent G, Nonclercq D, Journé F, Ghanem G, Duvillier H, Gabius HJ, Lechien J, Saussez S.

Int J Oncol. 2013 Jul;43(1):185-93. doi: 10.3892/ijo.2013.1944. Epub 2013 May 16.

PMID:
23677331
3.

Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2013 May;139(5):727-37. doi: 10.1007/s00432-013-1375-7. Epub 2013 Jan 25.

PMID:
23354841
4.

Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.

Tai SK, Yang MH, Chang SY, Chang YC, Li WY, Tsai TL, Wang YF, Chu PY, Hsieh SL.

Cancer Sci. 2011 Apr;102(4):895-902. doi: 10.1111/j.1349-7006.2011.01859.x. Epub 2011 Mar 4.

5.

Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.

Cheng RJ, Deng WG, Niu CB, Li YY, Fu Y.

Int J Gynecol Cancer. 2011 Aug;21(6):1004-12. doi: 10.1097/IGC.0b013e31821c45b7.

PMID:
21792010
6.

CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L.

World J Gastroenterol. 2012 May 14;18(18):2253-61. doi: 10.3748/wjg.v18.i18.2253.

7.

Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.

PMID:
24743512
8.

Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.

Xia W, Zhang F, Xie C, Jiang M, Hou M.

Stem Cell Res Ther. 2015 Apr 22;6:82. doi: 10.1186/s13287-015-0076-3.

9.

CD74 expression and its therapeutic potential in thyroid carcinoma.

Cheng SP, Liu CL, Chen MJ, Chien MN, Leung CH, Lin CH, Hsu YC, Lee JJ.

Endocr Relat Cancer. 2015 Apr;22(2):179-90. doi: 10.1530/ERC-14-0269. Epub 2015 Jan 19.

10.

Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, Morand EF, Hickey MJ.

J Immunol. 2011 Apr 15;186(8):4915-24. doi: 10.4049/jimmunol.1003713. Epub 2011 Mar 16.

11.

Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.

Richard V, Kindt N, Decaestecker C, Gabius HJ, Laurent G, Noël JC, Saussez S.

Oncol Rep. 2014 Aug;32(2):523-9. doi: 10.3892/or.2014.3272. Epub 2014 Jun 16.

12.

Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.

Marsh LM, Cakarova L, Kwapiszewska G, von Wulffen W, Herold S, Seeger W, Lohmeyer J.

Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L442-52. doi: 10.1152/ajplung.00525.2007. Epub 2009 Jan 9.

13.

Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74.

Xiong CJ, Huang B, Zhou Y, Cun YP, Liu LT, Wang J, Li CQ, Pan Y, Wang H.

PLoS One. 2012;7(8):e43984. doi: 10.1371/journal.pone.0043984. Epub 2012 Aug 27. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/a5edef40-e46d-4810-9008-dbda429ccc2c.

14.

CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder.

Choi JW, Kim Y, Lee JH, Kim YS.

Int J Urol. 2013 Feb;20(2):251-5. doi: 10.1111/j.1442-2042.2012.03128.x. Epub 2012 Aug 21.

15.

Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.

Le Hiress M, Tu L, Ricard N, Phan C, Thuillet R, Fadel E, Dorfmüller P, Montani D, de Man F, Humbert M, Huertas A, Guignabert C.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):983-97. doi: 10.1164/rccm.201402-0322OC.

PMID:
26203495
16.

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.

Cao W, Liu J, Xia R, Lin L, Wang X, Xiao M, Zhang C, Li J, Ji T, Chen W.

Oncotarget. 2016 Mar 22;7(12):14537-50. doi: 10.18632/oncotarget.7478.

17.

The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.

Li W, Liu M, Su Y, Zhou X, Liu Y, Zhang X.

Oncotarget. 2015 Dec 29;6(42):44480-94. doi: 10.18632/oncotarget.6256.

18.

Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.

Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M.

J Cell Sci. 2012 Jul 1;125(Pt 13):3210-20. doi: 10.1242/jcs.102210. Epub 2012 Mar 27.

19.

CD74 is a survival receptor on colon epithelial cells.

Maharshak N, Cohen S, Lantner F, Hart G, Leng L, Bucala R, Shachar I.

World J Gastroenterol. 2010 Jul 14;16(26):3258-66.

20.

HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.

Zhu G, Tang Y, Geng N, Zheng M, Jiang J, Li L, Li K, Lei Z, Chen W, Fan Y, Ma X, Li L, Wang X, Liang X.

Neoplasia. 2014 Feb;16(2):168-79. doi: 10.1593/neo.132034.

Supplemental Content

Support Center